View in EDS HTML Full Text PDF Full Text

Characterization and Management of Cytokine Release Syndrome From the MonumenTAL‐1 Study of Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma.

Saved in:
Bibliographic Details
Title: Characterization and Management of Cytokine Release Syndrome From the MonumenTAL‐1 Study of Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma.
Authors: van de Donk, Niels W. C. J.1 (AUTHOR) n.vandedonk@amsterdamumc.nl, Chari, Ajai2 (AUTHOR), Martin, Thomas3 (AUTHOR), Krishnan, Amrita4 (AUTHOR), Rasche, Leo5 (AUTHOR), Ye, Jing Christine6 (AUTHOR), Popat, Rakesh7 (AUTHOR), Lipe, Brea8 (AUTHOR), Rodriguez, Cesar9 (AUTHOR), Schinke, Carolina10 (AUTHOR), Skerget, Sheri11 (AUTHOR), Vishwamitra, Deeksha11 (AUTHOR), Verona, Raluca11 (AUTHOR), Gong, Jue11 (AUTHOR), Singh, Indrajeet11 (AUTHOR), Campagna, Michela12 (AUTHOR), Masterson, Tara11 (AUTHOR), Hilder, Brandi11 (AUTHOR), Tolbert, Jaszianne11 (AUTHOR), Renaud, Thomas13 (AUTHOR)
Source: Cancer Medicine. Oct2025, Vol. 14 Issue 19, p1-16. 16p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20457634
DOI:10.1002/cam4.71276